Hepatitis C Genotype 5 (GT 5)
Showing 1 - 25 of >10,000
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)
Completed
- Hepatitis C Virus Infection
- +2 more
- (no location specified)
Jul 9, 2021
Alcoholic Hepatitis, Sepsis Trial in Richmond (Vitamin C, Dextrose 5% in water)
Completed
- Alcoholic Hepatitis
- Sepsis
- Vitamin C
- Dextrose 5% in water
-
Richmond, VirginiaVirginia Commonwealth University
Aug 1, 2022
Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))
Completed
- Hepatitis C Virus Infection
- OBV/PTV/r) ± ribavirin (RBV)
- (no location specified)
May 9, 2020
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
San Diego, California
- +24 more
Jul 14, 2021
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
Immune Response in Patients With Hepatitis B and C Infection
Recruiting
- Hepatitis B
- Hepatitis C
-
Basildon, Essex, United KingdomBasildon Hospital
Apr 5, 2022
Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)
Active, not recruiting
- Hepatitis B, Chronic
- Tenofovir disoproxil fumarate
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto General Hospital
Nov 1, 2022
Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)
Completed
- Hepatitis C, Chronic
- Elbasvir, Grazoprevir 50-100Mg Oral Tablet
-
Riyadh, Saudi ArabiaKing Fahad Medical City
Nov 18, 2020
Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual
Recruiting
- Hepatitis C Virus Infection, Response to Therapy of
- Test and treat plus peer mentors
- Usual care
-
Birmingham, Alabama
- +3 more
Dec 9, 2022
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)
Active, not recruiting
- Aortic Valve Disease
- Aortic Valve Disorder
- Trifecta GT (Glide Technology) Valve
-
Rochester, Minnesota
- +26 more
Mar 10, 2022
Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +
Recruiting
- Chronic Hepatitis C Infection
- PR4 + LDV/SOF + ASV 4 wk
- +7 more
-
Beijing, Beijing, China
- +1 more
Aug 27, 2021
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric
Completed
- Hepatitis C Virus (HCV)
- Glecaprevir/pibrentasvir adult formulation
- Glecaprevir/pibrentasvir pediatric formulation
-
San Francisco, California
- +37 more
Sep 19, 2022